Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Finn

Showing results (311-320 of 407) with videos related to

Pageof 41
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 15, 2025
Immune cell transcriptional profiles from pre-vaccination peripheral blood predict immune response to preventative MUC1 cancer vaccineDaniel Y Yuan, Michelle L McKeague, Vineet K Raghu, et al.
Cancer Immunology Research|April 30, 2014
Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillanceUzoma K Iheagwara, Pamela L Beatty, Phu T Van, et al.
Research Quarterly for Exercise and Sport|June 10, 2015
Overview of the Hungarian National Youth Fitness StudyTamás Csányi, Kevin J Finn, Gregory J Welk, et al.
Molecular Pharmacology|April 6, 2007
Trapping of a nonpeptide ligand by the extracellular domains of the gonadotropin-releasing hormone receptor results in insurmountable antagonismTrudy A Kohout, Qiu Xie, Shelby Reijmers, et al.
Molecular Cancer Research : MCR|July 16, 2016
ERK/MAPK Signaling Drives Overexpression of the Rac-GEF, PREX1, in BRAF- and NRAS-Mutant MelanomaMeagan B Ryan, Alexander J Finn, Katherine H Pedone, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 22, 1998
Retroviral expression of MUC-1 human tumor antigen with intact repeat structure and capacity to elicit immunity in vivoR A Henderson, W M Konitsky, S M Barratt-Boyes, et al.
Emerging Infectious Diseases|April 22, 2022
Genomic Epidemiology of Global Carbapenemase-Producing Escherichia coli, 2015-2017Gisele Peirano, Liang Chen, Diego Nobrega, et al.
Cancer Research|August 15, 1996
Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1)R A Henderson, M T Nimgaonkar, S C Watkins, et al.
Scientific Reports|October 14, 2016
Structural basis for ligand recognition by a Cache chemosensory domain that mediates carboxylate sensing in Pseudomonas syringaeJodi L Brewster, James L O McKellar, Thomas J Finn, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2008
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strainsK J Shaw, S Poppe, R Schaadt, et al.
Pageof 41

Showing results (311-320 of 407) with videos related to

Sort By:
Pageof 41
European Journal of Cancer (Oxford, England : 1990)|August 15, 2025
Immune cell transcriptional profiles from pre-vaccination peripheral blood predict immune response to preventative MUC1 cancer vaccineDaniel Y Yuan, Michelle L McKeague, Vineet K Raghu, et al.
Cancer Immunology Research|April 30, 2014
Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillanceUzoma K Iheagwara, Pamela L Beatty, Phu T Van, et al.
Research Quarterly for Exercise and Sport|June 10, 2015
Overview of the Hungarian National Youth Fitness StudyTamás Csányi, Kevin J Finn, Gregory J Welk, et al.
Molecular Pharmacology|April 6, 2007
Trapping of a nonpeptide ligand by the extracellular domains of the gonadotropin-releasing hormone receptor results in insurmountable antagonismTrudy A Kohout, Qiu Xie, Shelby Reijmers, et al.
Molecular Cancer Research : MCR|July 16, 2016
ERK/MAPK Signaling Drives Overexpression of the Rac-GEF, PREX1, in BRAF- and NRAS-Mutant MelanomaMeagan B Ryan, Alexander J Finn, Katherine H Pedone, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 22, 1998
Retroviral expression of MUC-1 human tumor antigen with intact repeat structure and capacity to elicit immunity in vivoR A Henderson, W M Konitsky, S M Barratt-Boyes, et al.
Emerging Infectious Diseases|April 22, 2022
Genomic Epidemiology of Global Carbapenemase-Producing Escherichia coli, 2015-2017Gisele Peirano, Liang Chen, Diego Nobrega, et al.
Cancer Research|August 15, 1996
Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1)R A Henderson, M T Nimgaonkar, S C Watkins, et al.
Scientific Reports|October 14, 2016
Structural basis for ligand recognition by a Cache chemosensory domain that mediates carboxylate sensing in Pseudomonas syringaeJodi L Brewster, James L O McKellar, Thomas J Finn, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2008
In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strainsK J Shaw, S Poppe, R Schaadt, et al.
Pageof 41